Table 2.

Results of serum levels of immunoglobulins (Ig) and total lymphocyte count before the treatment initiation, 4 and 16 weeks after treatment termination.

		Before treatment I	4 weeks after treatment termination II	16 weeks after treatment termination III	Statistics
Autovaccine	Ig A (mg/dl)	172	170	154	I–III p<0.05
	Ig G (mg/dl)	992	1020	1140	I–III p<0.05
	Ig M (mg/dl)	91	95	77	NS*
	Lymphocytes (%)	36.9	35.8	33.1	NS*
PBL**	Ig A (mg/dl)	193	188	197	NS*
	Ig G (mg/dl)	1044	1042	1499	NS*
	Ig M (mg/dl)	139	136	122	NS*
	Lymphocytes (%)	36.5	37.1	33.1	NS*

^*NS – no statistical significance;

^**PBL – polyvalent bacterial lysate; mg/dl to g/l conversion factor: 0.01.